Gayle Marshall

AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer

D. Mark Hickinson, Teresa Klinowska, Georgina Speake et al. · Clinical Cancer Research · 2010 · 120 citations

Medicine, Oncology, Pharmacology +17

Isolation and antisense suppression of flavonoid 3', 5'-hydroxylase modifies flower pigments and colour in cyclamen

Murray R. Boase, D. H. LEWIS, Kevin M. Davies et al. · BMC Plant Biology · 2010 · 88 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial

Costanza Paoletti, Gaia Schiavon, Emily M. Dolce et al. · Clinical Cancer Research · 2018 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Spatially resolved deconvolution of the fibrotic niche in lung fibrosis

Michael Eyres, Joseph A. Bell, Elizabeth R. Davies et al. · Cell Reports · 2022 · 52 citations · Full text

Medicine, Cell Biology, Pathology +14

Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?

Caroline Seiler, Alan Sharpe, J. Carl Barrett et al. · BMC Clinical Pathology · 2016 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +16